( all charts from https://www.mauldineconomics.com/ ) Vanda...

( all charts from https://www.mauldineconomics.com/ )

Vanda Pharmaceuticals wins drug approval, stock soars

https://www.bizjournals.com/washington/stories/2009/05/04/daily67.html

Vanda Pharmaceuticals Inc. CEO Mihael Polymeropoulos described his emotional reaction to the e-mail attachment from the Food and Drug Administration late Wednesday evening in one word: relief.

No doubt an understandable response to the FDA’s unforeseeable turnaround this week to greenlight Vanda’s lead drug, iloperidone, as a marketable schizophrenia treatment — less than nine months after the agency rejected it as being unapprovable.






Atossa Genetics (ATOS) Reports FDA Approval of Oral Endoxifen for 'Expanded Access' as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient

https://www.streetinsider.com/Corpo...or a U.S. Breast Cancer Patient/15256553.html





Sarepta Wins Controversial FDA Approval for First DMD Drug

https://www.raps.org/regulatory-foc...controversial-fda-approval-for-first-dmd-drug



Surprise approval for Portola’s blood thinner has biotech eyeing a new dawn at the FDA

https://www.statnews.com/2017/06/23/portola-fda-approval/